Dr. Mitchell Shirvan
Chief Scientific and Development Officer
Other
Executive compensation
Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.
| Fiscal year | Company | Role | Salary | Total |
|---|---|---|---|---|
| 2024 | Silexion Therapeutics Corp (SLXN) | Chief Scientific and Development Officer | $190,286 | $1,301,490 |
| 2023 | Silexion Therapeutics Corp (SLXN) | Chief Scientific and Development Officer | $156,140 | $206,800 |
Earnings-call appearances
No earnings-call appearances recorded yet.